ArticleNeurogenetics2026
Severe neurodevelopmental phenotype with multisystem involvement in VPS16-related mucopolysaccharidosis-like syndrome.
Article in Neurogenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vacuolar protein sorting 16 (VPS16) functions in endolysosomal trafficking. Biallelic VPS16 variants cause a mucopolysaccharidosis-like syndrome reported in only four patients, with neurological involvement ranging from mild developmental delay to severe impairment with epilepsy and pyramidal signs. We report an additional patient biallelic for VPS16 NM_022575.4:c.2272-18 C > A, with profound developmental delay, early-onset epilepsy, and spasticity. Multisystem involvement included recurrent infections, neutropenia, serosal effusions, and tubular proteinuria. Brain MRI showed white-matter abnormalities, progressive cerebral and cerebellar atrophy, and symmetric signal changes in the globus pallidus and substantia nigra, suggestive of iron deposition, further expanding the neurological spectrum of this disorder.
Indexed as
Identifiers
42809161What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.